BG
IDIX

BlackRock Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-41,331
Closed -$996K – 2938
2014
Q2 		$996K Hold
41,331
– – ﹤0.01% 1839
2014
Q1 		$249K Hold
41,331
– – ﹤0.01% 2422
2013
Q4 		$247K Hold
41,331
– – ﹤0.01% 2379
2013
Q3 		$215K Buy
41,331
+14,531
+54% +$63.7K ﹤0.01% 2464
2013
Q2 		$97K Buy
+26,800
New +$110K ﹤0.01% 2367

BlackRock Group's IDIX Position: Q3 2014 in Review

BlackRock Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 41,331 shares — an estimated $996K sold.

BlackRock Group first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $996K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock Group sold 41,331 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $996K.
  • BlackRock Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock Group's IDENIX PHARMACEUTICALS INC position peaked at $996K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock Group's 13F filing for Q3 2014, filed 29 Oct 2014.